appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Ortin Global Ltd
ORTINLAB
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Ortin Laboratories Limited is engaged in the business of manufacturing and trading of pharmaceuticals, drugs and intermediates.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Name and Symbol Change
Ortin Laboratories Members has informed the Members of the Exchange that the name of the Company Ortin Laboratories Limited shall be changed to ORTIN GLOBAL LIMITED and symbol be changed to ORTINGLOBE w.e.f. September 03, 2024. | Download
Ortin Laboratories Members has informed the Members of the Exchange that the name of the Company Ortin Laboratories Limited shall be changed to ORTIN GLOBAL LIMITED and symbol be changed to ORTINGLOBE w.e.f. September 03, 2024. | Download
Appointment
Ortin Laboratories Limited has informed the Exchange regarding Appointment of Mr Ramesh Joshi as Executive Director of the company w.e.f. August 13, 2024. | Download
Ortin Laboratories Limited has informed the Exchange regarding Appointment of Mr Ramesh Joshi as Executive Director of the company w.e.f. August 13, 2024. | Download
Cash Dividend
Final • Div/Share: ₹ 0.25
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 6.13%